Apelin hormone injections powerfully lower blood sugarNovember 05, 2008By injecting a hormone produced by fat and other tissues into mice, researchers report in the November Cell Metabolism that they significantly lowered blood sugar levels in normal and obese mice. The findings suggest that the hormone known as apelin might be a promising target for managing insulin resistance and type 2 diabetes. Insulin resistance, in which normal amounts of insulin are insufficient to lower blood sugar (glucose) levels, is a precursor to diabetes. " The effects of apelin appear to be similar to insulin," although they operate in different ways, said Isabelle Castan-Laurell of Institut National de la Santé et de la Recherche Médicale and Université de Toulouse. Earlier studies had suggested a link between apelin and insulin, Castan-Laurell said. Apelin levels were shown to parallel insulin levels in mice and humans. Apelin levels in the blood also rise in those who are obese and in those with type 2 diabetes. Those findings led the researchers to suspect that apelin and insulin might have other similarities. Now, they show that acute intravenous injections of apelin have a powerful blood sugar-lowering effect on mice. They also show evidence that apelin stimulates muscle and fat tissue to take up glucose from the bloodstream by stimulating a known glucose transport pathway. Specifically, apelin activates a pathway including an enzyme called AMP-activated protein kinase (AMPK), which plays a pivotal role in the control of skeletal muscle glucose and the metabolism of fatty acids. Moreover, they showed that apelin treatment restores glucose tolerance and improves glucose uptake in mice that are obese and insulin resistant. Castan-Laurell said they aren't quite sure yet what it means that obese individuals tend to have high apelin levels. It could be that apelin levels don't rise enough to curb rising blood sugar or perhaps insulin resistance without apelin would be even worse. Alternatively, obese animals and humans might grow resistant to the action of apelin just as they do insulin. The researchers said they will now examine the effects of chronic apelin treatment in the mice to see if the hormone can ward of obesity and insulin resistance in the longer term. " In conclusion," the researchers wrote, "the present study reveals apelin as a new endocrine regulator of AMPK and strengthens the crosstalk between [fat] and skeletal muscle. The involvement of AMPK in apelin-mediated glucose uptake represents an attractive pathway that could conceivably lead to a new drug target for the treatment of metabolic disorders." Either way, they added, the discovery offers new insights into the physiology of glucose and lipid metabolism in health and disease. Cell Press |
|||||||||||||||||||||
| Related Blood Sugar Current Events and Blood Sugar News Articles Cancers' Sweet Tooth May Be Weakness The pedal-to-the-metal signals driving the growth of several types of cancer cells lead to a common switch governing the use of glucose, researchers at Winship Cancer Institute of Emory University have discovered. Researchers discover mechanism of insulin production that can lead to better treatment for diabetes How a specific gene within the pancreas affects secretion of insulin has been discovered by researchers from the Hebrew University of Jerusalem, in collaboration with Japanese and American universities. AAP supports the IDF guideline on oral health for people with diabetes New clinical guidelines released by the International Diabetes Foundation (IDF) emphasize the importance of periodontal health for people with diabetes. Researchers identify the three killer indicators that are even worse than high cholesterol Researchers at the University of Warwick have identified a particular combination of health problems that can double the risk of heart attack and cause a three-fold increase in the risk of mortality. UM Scientists Create Fruit Fly Model to Help Unravel Genetics of Human Diabetes As rates of obesity, diabetes, and related disorders have reached epidemic proportions in the US in recent years, scientists are working from many angles to pinpoint the causes and contributing factors involved in this public health crisis. Toward bold new anti-cancer medicines Bold new strategies in the battle against cancer may turn forms of the disease that presently are incurable into manageable conditions that can be controlled for long periods of time. Muscle weakness a common side effect of long stays in intensive care units After decades of focusing on the management of respiratory failure, circulatory shock and severe infections that lead to extended stays in hospital intensive care units, critical care researchers are increasingly turning attention to what they believe is a treatable complication developed by many who spend days or weeks confined to an ICU bed: debilitating muscle weakness that can linger long after hospital discharge. Research indicates vegetable juice can be an easy, enjoyable way to increase daily intake Decades of studies have documented the link between eating a diet rich in vegetables and multiple health benefits, yet nearly eight out of 10 people worldwide fall short of the daily recommendation. Mayo Clinic Clinicians Develop New Decision Aid Tool to Help Type 2 Diabetes Patients Mayo Clinic clinicians and designers, along with colleagues from other institutions, have developed and tested a tool to involve patients more in their diabetes treatment and medication choices. Monash research cautions against use of anti-oxidants An international team of scientists, led by Monash University researchers, has found that anti-oxidants commonly touted for their health-promoting benefits, could contribute to the early onset of Type 2 diabetes. More Blood Sugar Current Events and Blood Sugar News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||